[en] A debate is still open about the precise control exerted by the somatotrope GH-releasing hormone (GHRH)/growth hormone (GH)/insulin-like growth factor 1 axis on the immune system. The objective of this study was to directly address this question through the use of Ghrh−/− mice that exhibit a severe deficiency of their somatotrope axis. After control backcross studies and normalization for the reduced global weight of transgenic mice, no difference in weight and cellularity of the thymus was observed in Ghrh−/− mice when compared with C57BL/6 wild-type (WT) control mice. Similarly, no significant change was observed in frequency and number of thymic T cell subsets. In the periphery, Ghrh−/− mice exhibited an increase in T cell proportion associated with a higher frequency of sjTREC and naïve T cells. However, all Ghrh−/− mice displayed an absolute and relative splenic atrophy, in parallel with a decrease in B cell percentage. GH supplementation of transgenic mice for 6 weeks induced a significant increase in their global as well as absolute and relative splenic weight. Interestingly, the classical thymus involution following dexamethasone administration was shown to recover in WT mice more quickly than in mutant mice. Altogether, these data show that the severe somatotrope deficiency of Ghrh−/− mice essentially impacts the spleen and B compart- ment of the adaptive immune system, while it only marginally affects thymic function and T cell development.
Research center :
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège
Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A (1990) 87:6934-8. doi:10.1073/pnas.87.18.6934
Baroni C. Thymus, peripheral lymphoid tissues and immunological responsiveness of the pituitary dwarf mouse. Experientia (1967) 23:282-3. doi:10.1007/BF02135688
Baroni CD, Fabris N, Bertoli G. Effects of hormones on development and function of lymphoid tissues. Synergistic action of thyroxin and somatotropic hormone in pituitary dwarf mice. Immunology (1969) 17:303-14
Duquesnoy RJ. Immunodeficiency of the thymus-dependent system of the Ames dwarf mouse. J Immunol (1972) 108:1578-90
Kelley KW, Brief S, Westly HJ, Novakofski J, Bechtel PJ, Simon J, et al. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci U S A (1986) 83:5663-7. doi:10.1073/pnas.83.15.5663
Bodart G, Farhat K, Charlet-Renard C, Salvatori R, Geenen V, Martens H. The somatotrope growth hormone-releasing hormone/growth hormone/insulin-like growth factor-1 axis in immunoregulation and immunosenescence. Front Horm Res (2017) 48:147-59. doi:10.1159/000452913
Savino W, Dardenne M. Pleiotropic modulation of thymic functions by growth hormone: from physiology to therapy. Curr Opin Pharmacol (2010) 10:434-42. doi:10.1016/j.coph.2010.04.002
Napolitano LA, Schmidt D, Gotway MB, Ameli N, Filbert EL, Ng MM, et al. Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest (2008) 118:1085-98. doi:10.1172/JCI32830
Morrhaye G, Kermani H, Legros JJ, Baron F, Beguin Y, Moutschen M, et al. Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients. PLoS One (2009) 4:e5668. doi:10.1371/journal.pone.0005668
Dumont F, Robert F, BischoffP. T and B lymphocytes in pituitary dwarf Snell-Bagg mice. Immunology (1979) 38:23-31
Montecino-Rodriguez E, Clark RG, Powell-Braxton L, Dorshkind K. Primary B cell development is impaired in mice with defects of the pituitary/thyroid axis. J Immunol (1997) 159:2712-9
Schneider GB. Immunological competence in Snell-Bagg pituitary dwarf mice: response to the contact-sensitizing agent oxazolone. Am J Anat (1976) 145:371-93. doi:10.1002/aja.1001450306
Dorshkind K, Horseman ND. The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev (2000) 21:292-312. doi:10.1210/edrv.21.3.0397
Alba M, Salvatori R. A mouse with targeted ablation of the growth hormone-releasing hormone gene: a new model of isolated growth hormone deficiency. Endocrinology (2004) 145:4134-43. doi:10.1210/en.2004-0119
Alba M, Fintini D, Bowers CY, Parlow AF, Salvatori R. Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse. Am J Physiol Endocrinol Metab (2005) 289:E762-7. doi:10.1152/ajpendo.00203.2005
Alba M, Fintini D, Salvatori R. Effects of recombinant mouse growth hormone treatment on growth and body composition in GHRH knock out mice. Growth Horm IGF Res (2005) 15:275-82. doi:10.1016/j.ghir.2005.05.001
Alba M, Schally AV, Salvatori R. Partial reversibility of growth hormone (GH) deficiency in the GH-releasing hormone (GHRH) knockout mouse by postnatal treatment with a GHRH analog. Endocrinology (2005) 146:1506-13. doi:10.1210/en.2004-1044
Dulude G, Cheynier R, Gauchat D, Abdallah A, Kettaf N, Sekaly RP, et al. The magnitude of thymic output is genetically determined through controlled intrathymic precursor T cell proliferation. J Immunol (2008) 181:7818-24. doi:10.4049/jimmunol.181.11.7818
Kermani H, Goffinet L, Mottet M, Bodart G, Morrhaye G, Dardenne O, et al. Expression of the growth hormone/insulin-like growth factor axis during Balb/c thymus ontogeny and effects of growth hormone upon ex vivo T cell differentiation. Neuroimmunomodulation (2011) 18:137-47. doi:10.1159/000328844
Brooks KJ, Bunce KT, Haase MV, White A, Changani KK, Bate ST, et al. MRI quantification in vivo of corticosteroid induced thymus involution in mice: correlation with ex vivo measurements. Steroids (2005) 70:267-72. doi:10.1016/j.steroids.2004.11.013
Beckmann N, Gentsch C, Baumann D, Bruttel K, Vassout A, Schoeffter P, et al. Non-invasive, quantitative assessment of the anatomical phenotype of corticotropin-releasing factor-overexpressing mice by MRI. NMR Biomed (2001) 14:210-6. doi:10.1002/nbm.704
Barrat F, Lesourd BM, Louise A, Boulouis HJ, Vincent-Naulleau S, Thibault D, et al. Surface antigen expression in spleen cells of C57B1/6 mice during ageing: influence of sex and parity. Clin Exp Immunol (1997) 107:593-600. doi:10.1046/j.1365-2249.1997.3021199.x
Murphy WJ, Durum SK, Longo DL. Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo. J Immunol (1992) 149:3851-7
Montecino-Rodriguez E, Clark R, Johnson A, Collins L, Dorshkind K. Defective B cell development in Snell dwarf (dw/dw) mice can be corrected by thyroxine treatment. J Immunol (1996) 157:3334-40
Oliveira CR, Salvatori R, Nobrega LM, Carvalho EO, Menezes M, Farias CT, et al. Sizes of abdominal organs in adults with severe short stature due to severe, untreated, congenital GH deficiency caused by a homozygous mutation in the GHRH receptor gene. Clin Endocrinol (Oxf) (2008) 69:153-8. doi:10.1111/j.1365-2265.2007.03148.x
Jardieu P, Clark R, Mortensen D, Dorshkind K. In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. J Immunol (1994) 152:4320-7
Smaniotto S, Mendes-da-Cruz DA, Carvalho-Pinto CE, Araujo LM, Dardenne M, Savino W. Combined role of extracellular matrix and chemokines on peripheral lymphocyte migration in growth hormone transgenic mice. Brain Behav Immun (2010) 24:451-61. doi:10.1016/j.bbi.2009.11.014
Sumita K, Hattori N, Inagaki C. Effects of growth hormone on the differentiation of mouse B-lymphoid precursors. J Pharmacol Sci (2005) 97:408-16. doi:10.1254/jphs. FPJ04054X
Gagnerault MC, Postel-Vinay MC, Dardenne M. Expression of growth hormone receptors in murine lymphoid cells analyzed by flow cytofluorometry. Endocrinology (1996) 137:1719-26. doi:10.1210/endo.137.5.8612507
Clark R, Strasser J, McCabe S, Robbins K, Jardieu P. Insulin-like growth factor-1 stimulation of lymphopoiesis. J Clin Invest (1993) 92:540-8. doi:10.1172/JCI116621
Postel-Vinay MC, de Mello Coelho V, Gagnerault MC, Dardenne M. Growth hormone stimulates the proliferation of activated mouse T lymphocytes. Endocrinology (1997) 138:1816-20. doi:10.1210/endo.138.5.5108
Shohreh R, Pardo CA, Guaraldi F, Schally AV, Salvatori R. GH, but not GHRH, plays a role in the development of experimental autoimmune encephalomyelitis. Endocrinology (2011) 152:3803-10. doi:10.1210/en.2011-1317
Foster MP, Jensen ER, Montecino-Rodriguez E, Leathers H, Horseman N, Dorshkind K. Humoral and cell-mediated immunity in mice with genetic deficiencies of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormone. Clin Immunol (2000) 96:140-9. doi:10.1006/clim.2000.4889
Baroni C. Mouse thymus in hereditary pituitary dwarfism. Acta Anat (Basel) (1967) 68:361-73. doi:10.1159/000143040
Pierpaoli W, Baroni C, Fabris N, Sorkin E. Hormones and immunological capacity. II. Reconstitution of antibody production in hormonally deficient mice by somatotropic hormone, thyrotropic hormone and thyroxin. Immunology (1969) 16:217-30
Dorshkind K, Welniak L, Gault RA, Hixon J, Montecino-Rodriguez E, Horseman ND, et al. Effects of housing on the thymic deficiency in dwarf mice and its reversal by growth hormone administration. Clin Immunol (2003) 109:197-202. doi:10.1016/S1521-6616(03)00181-5
Chatterton RT Jr, Murray CL, Hellman L. Endocrine effects on leukocytopoiesis in the rat. I. Evidence for growth hormone secretion as the leukocytopoietic stimulus following acute cortisol-induced lymphopenia. Endocrinology (1973) 92:775-87. doi:10.1210/endo-92-3-775
Kelley KW, Dantzer R. Growth hormone and prolactin as natural antagonists of glucocorticoids in immunoregulation. In: PlotnikoffNP, Murgo A, Faith R, Wybran J, editors. Stress and Immunity. Boca Raton, Florida: CRC Press (1991). p. 433-51
Moutoussamy S, Kelly PA, Finidori J. Growth-hormone-receptor and cytokine-receptor-family signaling. Eur J Biochem (1998) 255:1-11. doi:10.1046/j.1432-1327.1998.2550001.x
Stocklin E, Wissler M, Gouilleux F, Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature (1996) 383:726-8. doi:10.1038/383726a0
Krishnan N, Thellin O, Buckley DJ, Horseman ND, Buckley AR. Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology (2003) 144:2102-10. doi:10.1210/en.2003-0053
Lepletier A, de Carvalho VF, Rodriguese Silva PM, Villar S, Perez AR, Savino W, et al. Trypanosoma cruzi disrupts thymic homeostasis by altering intrathymic and systemic stress-related endocrine circuitries. PLoS Negl Trop Dis (2013) 7:e2470. doi:10.1371/journal.pntd.0002470
Palmer DB. The effect of age on thymic function. Front Immunol (2013) 4:316. doi:10.3389/fimmu.2013.00316
Bartke A, Sun LY, Longo V. Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. Physiol Rev (2013) 93:571-98. doi:10.1152/physrev.00006.2012
Flurkey K, Papaconstantinou J, Miller RA, Harrison DE. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A (2001) 98:6736-41. doi:10.1073/pnas.111158898
Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution (1957) 11:398-411. doi:10.1111/j.1558-5646.1957.tb02911.x
Yamada M, Hato F, Kinoshita Y, Tominaga K, Tsuji Y. The indirect participation of growth hormone in the thymocyte proliferation system. Cell Mol Biol (Noisy-le-grand) (1994) 40:111-21